MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

Search

STAAR Surgical Co

Open

SectorHealthcare

27.23 -0.04

Overview

Share price change

24h

Current

Min

27.18

Max

27.47

Key metrics

By Trading Economics

Income

37M

-17M

Sales

1.7M

44M

Profit margin

-37.933

Employees

1,157

EBITDA

48M

-23M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

-3.13% downside

Dividends

By Dow Jones

Next Earnings

29 paź 2025

Market Stats

By TradingEconomics

Market Cap

409M

1.3B

Previous open

27.27

Previous close

27.23

News Sentiment

By Acuity

67%

33%

334 / 371 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

STAAR Surgical Co Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

2 wrz 2025, 23:07 UTC

Acquisitions, Mergers, Takeovers

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

5 sie 2025, 10:10 UTC

Acquisitions, Mergers, Takeovers

Alcon to Buy Staar Surgical for $1.5 Billion

26 wrz 2025, 21:56 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical, Insight Enterprises, and More Stocks See Action From Activist Investors -- Barrons.com

22 wrz 2025, 11:15 UTC

Acquisitions, Mergers, Takeovers

STAAR Surgical Announces Expiration of 'Window Shop' Period; No Competing Acquisition Proposals Received

16 wrz 2025, 13:12 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical Board Believes Value Provided by Alcon Merger Exceeds What STAAR Could Achieve on Standalone Basis in Foreseeable Future >STAA

16 wrz 2025, 13:12 UTC

Acquisitions, Mergers, Takeovers

STAAR Board Unanimously Determined Proposed Merger With Alcon Is in Best Interests of Co, Stockholders >STAA

16 wrz 2025, 13:11 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical Will Hold Special Meeting of Stockholders on Oct 23 >STAA

16 wrz 2025, 13:10 UTC

Acquisitions, Mergers, Takeovers

STAAR Surgical Bd of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders

8 sie 2025, 13:40 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Staar Surgical's Top Holder Questions Deal -- Market Talk

5 sie 2025, 05:07 UTC

Acquisitions, Mergers, Takeovers

Alcon Deal Puts STARR Equity Value at Approximately $1.5 Billion. >ALC.EB

5 sie 2025, 05:07 UTC

Acquisitions, Mergers, Takeovers

Alcon Will Purchase All Outstanding Shares of STAAR Common Stock for $28 Per Share in Cash >ALC.EB

5 sie 2025, 05:07 UTC

Acquisitions, Mergers, Takeovers

Alcon Deal Represents 51% Premium to Closing Price of STAAR Common Stock on Aug. 4 >ALC.EB

5 sie 2025, 05:07 UTC

Acquisitions, Mergers, Takeovers

Alcon Agrees to Acquire STAAR Surgical >ALC STAA

5 sie 2025, 05:01 UTC

Acquisitions, Mergers, Takeovers

Alcon Agrees To Acquire STAAR Surgical >ALC STAA

Peer Comparison

Price change

STAAR Surgical Co Forecast

Price Target

By TipRanks

-3.13% downside

12 Months Forecast

Average 26.33 USD  -3.13%

High 28 USD

Low 18 USD

Based on 8 Wall Street analysts offering 12 month price targets forSTAAR Surgical Co - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

8 ratings

0

Buy

8

Hold

0

Sell

Technical Score

By Trading Central

18.604 / 20.07Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Very Strong Bullish Evidence

Long Term

No Evidence

Sentiment

By Acuity

334 / 371 Ranking in Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
help-icon Live chat